End-of-day quote
BURSA MALAYSIA
03:30:00 24/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.46
MYR
|
-1.08%
|
|
-5.15%
|
-3.16%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
486.1
|
460.5
|
1,743
|
615.3
|
281
|
275
|
Enterprise Value (EV)
1 |
466.8
|
526.1
|
1,791
|
544.9
|
78.56
|
71.5
|
P/E ratio
|
14.7
x
|
16.5
x
|
52
x
|
2.21
x
|
-6.65
x
|
-7.47
x
|
Yield
|
1.16%
|
1.9%
|
-
|
2.83%
|
-
|
-
|
Capitalization / Revenue
|
1.15
x
|
0.97
x
|
3.41
x
|
0.65
x
|
0.46
x
|
0.84
x
|
EV / Revenue
|
1.11
x
|
1.11
x
|
3.51
x
|
0.58
x
|
0.13
x
|
0.22
x
|
EV / EBITDA
|
8.91
x
|
10
x
|
26.9
x
|
1.39
x
|
-4.75
x
|
-8.8
x
|
EV / FCF
|
-21
x
|
-8.45
x
|
243
x
|
7.54
x
|
3.12
x
|
4.5
x
|
FCF Yield
|
-4.76%
|
-11.8%
|
0.41%
|
13.3%
|
32.1%
|
22.2%
|
Price to Book
|
1.98
x
|
1.6
x
|
5.61
x
|
1.06
x
|
0.31
x
|
0.32
x
|
Nbr of stocks (in thousands)
|
5,61,949
|
5,82,949
|
5,82,949
|
5,80,443
|
5,79,350
|
5,79,000
|
Reference price
2 |
0.8650
|
0.7900
|
2.990
|
1.060
|
0.4850
|
0.4750
|
Announcement Date
|
30/05/18
|
31/05/19
|
28/05/20
|
24/05/21
|
20/04/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
421.2
|
474
|
510.7
|
946.4
|
606.7
|
325.9
|
EBITDA
1 |
52.38
|
52.42
|
66.49
|
392.8
|
-16.54
|
-8.124
|
EBIT
1 |
40.03
|
36.5
|
44.8
|
365.4
|
-61.3
|
-52.92
|
Operating Margin
|
9.51%
|
7.7%
|
8.77%
|
38.61%
|
-10.1%
|
-16.24%
|
Earnings before Tax (EBT)
1 |
41.12
|
35.44
|
41.56
|
363.3
|
-60.16
|
-47.96
|
Net income
1 |
35.9
|
27.9
|
33.18
|
280.2
|
-42.3
|
-36.81
|
Net margin
|
8.52%
|
5.88%
|
6.5%
|
29.61%
|
-6.97%
|
-11.3%
|
EPS
2 |
0.0588
|
0.0479
|
0.0575
|
0.4807
|
-0.0729
|
-0.0636
|
Free Cash Flow
1 |
-22.24
|
-62.25
|
7.368
|
72.22
|
25.21
|
15.9
|
FCF margin
|
-5.28%
|
-13.13%
|
1.44%
|
7.63%
|
4.16%
|
4.88%
|
FCF Conversion (EBITDA)
|
-
|
-
|
11.08%
|
18.39%
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
22.21%
|
25.77%
|
-
|
-
|
Dividend per Share
2 |
0.0100
|
0.0150
|
-
|
0.0300
|
-
|
-
|
Announcement Date
|
30/05/18
|
31/05/19
|
28/05/20
|
24/05/21
|
20/04/23
|
25/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
65.6
|
48.3
|
-
|
-
|
-
|
Net Cash position
1 |
19.3
|
-
|
-
|
70.4
|
202
|
204
|
Leverage (Debt/EBITDA)
|
-
|
1.251
x
|
0.7269
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-22.2
|
-62.2
|
7.37
|
72.2
|
25.2
|
15.9
|
ROE (net income / shareholders' equity)
|
15.9%
|
10.7%
|
11.3%
|
62.8%
|
-4.63%
|
-4.18%
|
ROA (Net income/ Total Assets)
|
9.02%
|
5.99%
|
5.97%
|
36%
|
-3.53%
|
-3.38%
|
Assets
1 |
397.9
|
465.9
|
555.9
|
779
|
1,198
|
1,088
|
Book Value Per Share
2 |
0.4400
|
0.4900
|
0.5300
|
1.000
|
1.540
|
1.500
|
Cash Flow per Share
2 |
0.0500
|
0.0400
|
0.0600
|
0.2100
|
0.2300
|
0.2400
|
Capex
1 |
34.7
|
63.7
|
50.8
|
127
|
50.2
|
14
|
Capex / Sales
|
8.24%
|
13.44%
|
9.94%
|
13.47%
|
8.27%
|
4.31%
|
Announcement Date
|
30/05/18
|
31/05/19
|
28/05/20
|
24/05/21
|
20/04/23
|
25/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.16% | 5.65Cr | | +9.92% | 2.74TCr | | +17.41% | 229.65Cr | | +10.45% | 230.29Cr | | -51.12% | 223.03Cr | | -32.99% | 200.79Cr | | +18.89% | 181.9Cr | | -17.93% | 172.85Cr | | +6.12% | 132.63Cr | | +23.78% | 124.02Cr |
Medical Supplies
|